WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: APRIL ISSUE PUBLISHED
  • April Issue has been successfully launched on 1 April 2024.

Abstract

IN SILICO ADME-TOX PROFILLING OF SOME BENZIMIDAZOLE ANALOGUES

Amrutkar Rakesh D.*, Pawar Snehal D. and Pawar Sonali D.

ABSTRACT

Benzimidazole is a heterocyclic aromatic compound. It is an important pharmacophore that have much application in pharmaceutical chemistry and drug development. It is moiety of choice which possess many pharmacological properties. Within this study we used some new computational tools for predicting absorption, distribution, metabolism, elimination and toxicity. The compound showed that their ProTox-II tool was used to predicts such as hypotoxicity, carcinogenicity, immunotoxicity, mutagenicity, cytotoxicity, toxicity targets and their LD50.

Keywords: Pharmacokinetics, Druglikeness, Toxicity, Hypotoxicity, Carcinogenicity, Immunotoxicity, Mutagenicity.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More